Fibromyalgia: The Health Professional's Guide
You will receive 1 credit(s) of continuing education credit upon successful completion of this course. The purchase price of this course is $49.00


A surprisingly large number of individuals suffer from fibromyalgia syndrome. These patients often present in the dental practice with complaints of chronic facial pain. The oral health professionals need to be aware of the many facets of fibromyalgia in order to recognize and assist in the management of the disorder.

Learning Objectives:

Upon completion of this course, participants should be able to do the following:


  1. Recognize the symptoms of fibromyalgia syndrome.
  2. Be familiar with the diagnostic criteria for fibromyalgia syndrome and know how to differentiate it from similar disorders within the scope of the oral health professional.
  3. Direct patients to competent medical care for fibromyalgia syndrome.
  4. Be familiar with the current theories of the etiology of fibromyalgia syndrome.
  5. Be familiar with the treatment currently used for this disorder.
  6. Be able to provide the best care and support possible from the oral health professional.



is designed to assist the dentist and dental hygienist in developing a comprehensive understanding of the disorder and how it is managed over the long term. Fibromyalgia syndrome is an under diagnosed disorder of unknown etiology affecting as much as five percent of the general population. Symptoms include chronic pain, and often this is chronic facial pain. Associated disorders are presented, and current diagnostic criteria are given. The proper referrals and various treatments and their effectiveness are presented. A strong emphasis is placed on the differential diagnosis that needs to be done when a patient presents with chronic facial pain. The patient with fibromyalgia syndrome may never be cured, and lifestyle changes to improve the quality of life are discussed.



  1. Introduction
  2. Etiology
  3. Risk Factors
  4. Diagnosing and screening
  5. Management
  6. Summary

  1. Strand R. Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome. Arthritis Res Ther 2006;8:208-212.
  2. Croft P, Schollum J, Silman A. Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 1994;309:696-699.
  3. Kurland JE, Coyle WJ, Winkler A, Zable E. Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci 2006;51:454-460.
  4. Gowers WR. Lumbago – its lessons and analogues. BMJ 1904;1:117-121.
  5. 5. Goldenberg D. Fibromyalgia syndrome: an emerging but controversial condition. JAMA 1987;257:2802-2810.
  6. Wolfe F, Smythe HA, Yunus MB. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-172.
  7. Williams WE. Fibromyalgia: a comprehensive approach. New York: Walker & Co.; 1996.
  8. Kroenke K, Harris L. Symptoms research: a fertile field. Ann Intern Med 2001;134:801-802.
  9. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol 2005; 32 Suppl 75:6-21.
  10. Yunus MB, Khan MA, Rowlings KK, Green JR, Olson JM, Shad S. Genetic linkage analysis of multicase families with fibromyalgia syndrome. J Rheumatol 1999;26:408-412.
  11. Ressler KJ, Nemeroff CB. Roll of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000;12 Suppl 1:2-19.
  12. Schwarz MJ, Spath M, Muller-Bardorff H, Pongratz DE, Bondy B, Achenheil M. Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Neurosci Lett 1999;259:196-198.
  13. Carrasco GA, Van de Kar LD. Neuroendocrine pharmacology of stress. Eur J Pharmacol 2003;463:235-272.
  14. Greenen R, Jacobs JW, Bijlsma JW. Evaluation and management of endocrine dysfunction in fibromyalgia. Rheum Dis Clin North Am 2002;28:389-404.
  15. Clauw DJ. Elusive syndromes: treating the biologic basis of fibromyalgia and related syndromes. Cleve Clin J Med 2001;68:832-824.
  16. Epstein SA, Kay G, Clauw D. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 1999;40:57-63.
  17. Carskadon MA. Dement WC. Normal human sleep: an overview. In Kryger MH, Roth T, Dement WC. Principles and practice of sleep medicine, ed.2. Philadelphia: W.B. Saunders & Co.;1994:16-25.
  18. Slavkin HC. Chronic disabling diseases and disorders: the challenges of fibromyalgia. JADA 1997;128:1583-1589.
  19. Travell J, Simons D. Travell and Simons’ myofascial pain and dysfunction: the trigger point manual Vol. II, ed.1. Baltimore: Williams & Wilkins; 1992:440.
  20. May KP. Sleep apnea in male patients with the fibromyalgia syndrome. Am J Med 1993;94:505-508.
  21. Mease S, Simons DG. Muscle pain: understanding its nature, diagnosis and treatment. Baltimore: Lippincott; 2000:3-5.
  22. Crofford LJ, Clauw DJ. Fibromyalgia: where are we a decade after the American College of Rheumatology classification criteria were developed? Arthritis Rheum 2002; 46:1136-1138.
  23. Kroenke K, Harris L. Symptoms research: a fertile field. Ann Intern Med 2001; 134:801-802.
  24. Hudson JI, Mangweth B, Pope HG Jr. Family study of affective spectrum disorder. Arch Gen Psychiatry 2003; 60:170-177.
  25. Geisser ME, Casey KL, Brocksch CB. Perception of noxious and innocious heat stimulation among healthy women and women with fibromyalgia. Pain 2003; 102:243-250.
  26. Gracely RM, Grant MA, Giesecke T. Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol 2003; 17:593-6-9.
  27. Giesecker T, Williams DA, Harris RE. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 2003; 48:2916-2922.
  28. Ehrlich GE. Pain is real: fibromyalgia isn’t. J Rheumatol 2003; 30:1666-1667.
  29. Buskila D, Sarzi-Puttini P. Biology and therapy of fibromyalgia. New therapies in fibromyalgia. Arthritis Res Ther 2006; 8:218-242.
  30. White KP, Nielson WR, Harth M, Ostbye T, Speechley M. Does the label “fibromyalgia” alter health status, function, and health service utilization? Arthritis Rheum 2002; 47:260-265.
  31. Alamo M, Morall RR, Perula de Torres LA. Evaluation of a patient-centered approach in generalized musculoskeletal chronic pain/fibromylagia patients in primary care. Patient Educ Couns 2002; 48:23-31.
  32. McCain GA. Role of physical fitness training in the fibrositis/fibromyalgia syndrome. Am J Med 1986; 81:73-77.
  33. Jones KD, Burckhardt C, Clark SR, Bennett RM, Potempa KM. A randomized controlled trial of muscle strengthening versus flexibility training in fibromyalgia. J Rheumatol 2002; 29:1041-1048.
  34. Mannerkorpi K, Ahlmen M, Ekdahl C. Six- and 24-month follow-up of pool exercise therapy and education for patients with fibromyalgia. Scand J Rheumatol 2002; 31:306-310.
  35. Saskin P. Sleep and post-traumatic rheumatic pain modulation disorder (Fibrositis syndrome). Psychosom Med 1986; 48:319-325.
  36. Hadhazy V, Ezzo JM, Berman BM, Creamer P, Bausell B. Mind and body therapy for fibromyalgia: a systematic review. J Rheumatol 2000; 27:2911-2918.
  37. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004; 292:2388-2395.
  38. O’Malley PG, Balden E, Tomkins G. Treatment of fibromyalgia with antidepressants. J Gen Intern Med 2000; 15:659-666.
  39. Bennett RM, Kamin M, Karin R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain. Am J Med 2003; 114:537-545.
  40. Arnold LM, Hess EV, Hundon JI, Berno SE, Keck PEA. Randomized, placebo-controlled double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002; 112:191-197.
  41. Sayar K, Aksu G, Aki I, Tosum M. Venlafaxine treatment of fibromyalgia. Ann Pharmacother 2003; 37:1561-1565.
  42. Gendreau RM, Mease PJ, Rao SR, Kranzler JD, Clauw DJ. Minacipran: a potential new treatment of fibromyalgia Arthritis Rheum 2003; [abstract] 48:5616.
  43. Arnold LM, Lu Y, Crofford LJ. A double-blind multicenter trial comparing duloxetine to placebo in the treatment of fibromyalgia with or without major depressive disorder. Arthritis Rheum 2004; 50:2974-2984.
  44. Crofford L, Russell IJ, Mease P. Pregabalin improves pain associated with fibromyalgia syndrome in a multicenter, randomized, placebo-controlled monotherapy trial. Arthritis Rheum 2002 [Abstract] 46:S613.
  45. Deluze C, Bosia L, Zibs A, Chantraine A, Visher TL. Electroacupuncture in fibromyalgia: results of a controlled trial. BMJ 1992; 305:1249-1252.
  46. Martin DP, Sletten CD, Williams BA, Berger IH. Improvement in fibromyalgia symptoms with acupuncture: results of a randomized controlled trial. Mayo Clin Proc 2006; 81:749-757.
  47. Wilk G, Fisher H, Bragee B, Finer B, Fredrikson M. Functional anatomy of hypnotic analgesia: a PET study of patients with fibromyalgia. Dur J Pain 1999; 3:7-12.
  48. Ferraccioli G, Ghirelli L, Scita F. EMG-biofeedback training in fibromyalgia syndrome. J Rheumatol 1987; 14:820-825.
  49. Buskila D, Abu-Shakra M, Neumann L. Balneotherapy for fibromyalgia at the Dead Sea. Rheumatol Int 2000; 20:105-108.
  50. Blunt KL, Rajwani MH, Guerriero RC. The effectiveness of chiropractic management of fibromyalgia patients. Manipulative Physiol Ther 1997; 20:389-399.
  51. Brattberg G. Connective tissue massage in the treatment of fibromyalgia. Eur J Pain 1993; 3:235-244.
  52. Almeida TF, Roizenblatt S, Benedito-Silva AA, Tufik S. The effect of combined therapy (ultrasound and interferential current) on pain and sleep in fibromyalgia. Pain 2003; 104:665-672.
  53. Hayden JR, Louis DS, Doro C. Fibromyalgia and myofascial pain syndromes and the workers’ compensation environment: an update. Clin Occup Environ Med 2006; 5:455-469.
  54. Lofgren M, Ekholm J, Ohman A. ‘A constant struggle’: successful strategies of women in work despite fibromyalgia. Disabil Rehabil 2006; 28:447-455.
  55. Wolfe F, Katz RS, Michaud K. Jaw pain: its prevalence and meaning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia. J Rheumatol 2005; 32:2421-2428.
  56. Hall S. Common pain scenarios. Aus Fam Physician 1999; 28:31-32.

American Dental Association is an ADA CERP Recognized Provider.

ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.